Analyse de la mortalité en excès par cancer : modélisations corrigeant le manque de variables supplémentaires dans les tables de mortalité |
|
Analysis of excess mortality by cancer : modelling adjusting the absence of additional covariates in the life tables. |
|
Apports de l'analyse de séquences et de la modélisation par agent pour l'évaluation économique des stratégies de prise en charge de pathologies chroniques : applications à la prise en charge des cancers thyroïdiens et du VIH |
|
Clinical epidemiology of primary tumors of the central nervous system and gliomas specifically. |
|
Contributions méthodologiques à l'estimation de la survie nette : comparaison des estimateurs et tests des hypothèses du modèle du taux en excès |
|
Contributions of sequence analysis ans agent-based modeling for the economic evaluation of chronic diseases management strategies : applications to the management of throid cancers and HIV. |
|
Déterminants de la décision thérapeutique et analyse coût efficacité de la prise en charge thérapeutique initiale : étude sur une base de population : exemple du cancer de la prostate |
|
Determinants of fatigue in frail elderly patients with a non-hodgkin's lymphoma. |
|
The embodiment of adverse childhood experiences and cancer development: potential biological mechanisms and pathways across the life course. |
|
Enabling the transferability of complex interventions: exploring the combination of an intervention's key functions and implementation |
|
Endocrine disruptors and thyroid cancers. |
|
Epidémiologie clinique des tumeurs primitives du système nerveux central et en particulier des gliomes |
|
Épidémiologie des mélanomes de 1983 à 2003 d'après le registre des cancers du Tarn |
|
[Estimate of regional prevalence of colorectal cancer in France] |
|
Estimation and prognosis value of elderly colorectal cancer patients' quality of life. : A population-based study. |
|
Évolution de la démographie et de la longévité dans les prochaines décades : impact sur l’incidence des cancers urologiques |
|
FACTEURS PREDICTIFS DU DECES DANS UNE POPULATION RURALE AGEE : ENQUETE LONGITUDINALE HAUTE-GARONNE, 1982-1986 |
|
Facteurs psycho-sociaux associés à la fatigue chez des patients âgés fragiles atteints d'un lymphome non hodgkinien : rôle de la dépression, du coping, du soutien social et de la routinisation |
|
Factors determining the therapeutic decision and cost-effectiveness analysis of the initial therapeutic management : a population-based survey about prostatic neoplasm. |
|
Fin de vie de patients cancéreux : histoires de patients et opinions de médecins généralistes |
|
Guideline sheets on the side effects of anticancer drugs are useful for general practitioners |
|
Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry |
|
Incidence et survie des patients atteints d'un cancer de la vessie dans les départements du Tarn et de l'Isère entre 1990 et 1994 |
|
Incidence of thyroid cancer in adults recorded by French cancer registries |
|
[Informal and professional assistance in persons aged 75 years and over] |
|
[An intervention research program (AAPRISS) to reduce social inequalities in health: methods and validation]. |
|
Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983-2002. |
|
[Larynx cancer in France: descriptive epidemiology and incidence estimation] |
|
L'interdisciplinarité en action : les « mots-pièges » d'une recherche interdisciplinaire |
|
Men’s adherence regarding prostate cancer screening : the role of the information. |
|
Mesure de la survie des patients cancéreux en population à partir des registres de cancers : intérêts et limites |
|
Methodological considerations in cost of prostate cancer studies: a systematic review |
|
Methodological contribution to net survival estimation : estimator comparison and test of the parametric hazard model assumption. |
|
The multi-source information system of the Poitou-Charentes population-based cancer registry. Design, development and applications in the era of massive health data. |
|
National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: Is this estimation correct? |
|
Non-medical exposure to radioiodines and thyroid cancer |
|
La participation des hommes au dépistage du cancer de la prostate : le rôle de l'information |
|
[Participation factors in a occupational health colorectal cancer screening program] |
|
Perturbateurs endocriniens et cancer de la thyroïde |
|
Place du médecin généraliste dans la nouvelle organisation des soins en cancérologie |
|
Place of the general practitioner in the new organization of the care in cancer research in France. |
|
[Prevalence of cancer, health care and daily life assistance in people aged 75 or over living in the Tarn area (France)] |
|
Primary care physicians and oncologists are partners in cancer announcement |
|
Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis |
|
[Prostate cancer in Isère and Tarn (France) between 1985 and 1995: evolution of therapeutic indications] |
|
[Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990] |
|
Prostate cancer treatment in Europe at the end of 1990s |
|
Recommandations pour la mise en place d'un dispositif de surveillance épidémiologique nationale des cancers thyroïdiens |
|
Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri. |
|
[Risk of second non-germ cell cancer after treatment of stage I-II testicular seminoma] |
|
Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study. |
|
Socioeconomic status and site-specific cancer incidence, a Bayesian approach in a French Cancer Registries Network study. |
|
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe |
|
Subregional variations of dietary consumption and incidences of cancers in southern France |
|
Sur-traitement et sous traitement du cancer de la prostate en Midi-Pyrénées |
|
Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM) |
|
Survival of women with breast cancer in France: variation with age, stage and treatment |
|
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference |
|
[Therapeutic management of colonic cancer in France] |
|
[Time trends in the geographic variation of thyroid cancer incidence by tumor size from 1983 to 2000 in France]. |
|
Total and partial cancer prevalence in the adult French population in 2008 |
|
Treatment and prognosis of hepatocellular carcinoma: a population based study in France. |
|
[Treatment of cancer of the rectum. Practical survey based on 7 French departments in 1990] |
|
Trends in Kaposi's sarcoma survival disparities in the United States: 1980 through 2004. |
|
Trends in net survival from prostate cancer in six European Latin countries |
|
Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients |
|
Unbiased estimates of long-term net survival of solid cancers in France |
|
Use of mammography as a breast cancer screening tool in six districts in France |
|
Valeur prédictive et sensibilité du programme de médicalisation des systèmes d’information (PMSI) par rapport aux registres des cancers : application au cancer de la thyroïde (1999-2000) |
|
Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study. |
|
[Variations of the practice of radical prostatectomy in France] |
|